Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Tomball, TX
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Tomball, TX
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Richmond, VA
A Study of LY2189102 in Patients With Type 2 Diabetes
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel Design Study in Patients With Type 2 Diabetes Mellitus Who Are Stable on Diet and Exercise, With or Without Metformin Monotherapy.
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Miami, FL
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Topeka, KA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Nashua, NH
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Mesa, AZ
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Concord, CA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Escondido, CA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Fresno, CA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Spring Valley, CA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
New Port Richey, FL
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Oviedo, FL
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Oviedo, FL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Roswell, GA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Chicago, IL
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Crystal Lake, IL
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Bloomington, IN
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Bloomington, IN
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Bangor, ME
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Rockville, MD
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Springfield, MO
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Toms River, NJ
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Durham, NC
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Raleigh, NC
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Akron, OH
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Delaware, OH
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Delaware, OH
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Jackson, TN
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Memphis, TN
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Austin, TX
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Dallas, TX
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Round Rock, TX
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Bountiful, UT
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Federal Way, WA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Federal Way, WA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Olympia, WA
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Milwaukee, WI
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated:  3/17/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Beroun,
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
A Comparison of LY2605541 Versus Insulin Glargine Alone or in Combination With Pre-study Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin: An Open-Label, Randomized Study The IMAGINE 5 Study
Status: Enrolling
Updated: 3/17/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Beroun,
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Aurora, CO
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Topeka, KA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Concord, CA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Escondido, CA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Fresno, CA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Tustin, CA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Roswell, GA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Crystal Lake, IL
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Des Moines, IA
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Lexington, KY
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated:  3/17/2018
Clinical Research Facility
mi
from
Greer, SC
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
A Comparison of LY2605541 Once Daily at a Fixed Time With LY2605541 Variable Time of Dosing in Participants With Type 1 Diabetes Mellitus: An Open Label, Randomized, Crossover Study
Status: Enrolling
Updated: 3/17/2018
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials